Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Irene Feroce

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Cancers|June 10, 2022
Comment on Colletti et al. Prevalence and Management of Cancer of the Rectal Stump after Total Colectomy and Rectal Sparing in Patients with Familial Polyposis: Results from a Registry-Based Study. <i>Cancers</i> 2022, <i>14</i>, 298Davide Serrano, Irene Feroce, Bernardo Bonanni, et al.
Oncology Letters|February 14, 2018
<i>BRCA1</i> homozygous unclassified variant in a patient with non-Fanconi anemia: A case reportDavide Bondavalli, Francesca Malvestiti, Valeria Pensotti, et al.
Oncology Letters|August 28, 2018
Erratum: <i>BRCA1</i> homozygous unclassified variant in a patient with non-Fanconi anemia: A case reportDavide Bondavalli, Francesca Malvestiti, Valeria Pensotti, et al.
Journal of Biomedicine & Biotechnology|April 14, 2012
Fenretinide (4-HPR): a preventive chance for women at genetic and familial risk?Massimiliano Cazzaniga, Clara Varricchio, Chiara Montefrancesco, et al.
Plos One|April 8, 2022
A randomized controlled trial comparing self-referred message to family-referred message promoting men's adherence to evidence-based guidelines on BRCA1/2 germline genetic testing: A registered study protocolSerena Petrocchi, Giulia Ongaro, Mariarosaria Calvello, et al.
Current Oncology (Toronto, Ont.)|April 21, 2022
Psychological Determinants of Men's Adherence to Cascade Screening for <i>BRCA1/2</i>Giulia Ongaro, Serena Petrocchi, Mariarosaria Calvello, et al.
American Journal of Men'S Health|August 7, 2025
Can Family Motivation Enhance Men's Uptake of Cascade Screening for Familial <i>BRCA1/2</i> Mutations?Giulia Ongaro, Serena Petrocchi, Mariarosaria Calvello, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 20, 2008
Psychological and clinical factors implicated in decision making about a trial of low-dose tamoxifen in hormone replacement therapy usersGabriella Rondanina, Matteo Puntoni, Gianluca Severi, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 12, 2015
Difficult choices for young patients with cancer: the supportive role of decisional counselingLeonora Chiavari, Sara Gandini, Irene Feroce, et al.
Cancer Prevention Research (Philadelphia, Pa.)|October 25, 2018
Quality of Life in a Randomized Breast Cancer Prevention Trial of Low-Dose Tamoxifen and Fenretinide in Premenopausal WomenDavide Serrano, Sara Gandini, Aliana Guerrieri-Gonzaga, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Cancers|June 10, 2022
Comment on Colletti et al. Prevalence and Management of Cancer of the Rectal Stump after Total Colectomy and Rectal Sparing in Patients with Familial Polyposis: Results from a Registry-Based Study. <i>Cancers</i> 2022, <i>14</i>, 298Davide Serrano, Irene Feroce, Bernardo Bonanni, et al.
Oncology Letters|February 14, 2018
<i>BRCA1</i> homozygous unclassified variant in a patient with non-Fanconi anemia: A case reportDavide Bondavalli, Francesca Malvestiti, Valeria Pensotti, et al.
Oncology Letters|August 28, 2018
Erratum: <i>BRCA1</i> homozygous unclassified variant in a patient with non-Fanconi anemia: A case reportDavide Bondavalli, Francesca Malvestiti, Valeria Pensotti, et al.
Journal of Biomedicine & Biotechnology|April 14, 2012
Fenretinide (4-HPR): a preventive chance for women at genetic and familial risk?Massimiliano Cazzaniga, Clara Varricchio, Chiara Montefrancesco, et al.
Plos One|April 8, 2022
A randomized controlled trial comparing self-referred message to family-referred message promoting men's adherence to evidence-based guidelines on BRCA1/2 germline genetic testing: A registered study protocolSerena Petrocchi, Giulia Ongaro, Mariarosaria Calvello, et al.
Current Oncology (Toronto, Ont.)|April 21, 2022
Psychological Determinants of Men's Adherence to Cascade Screening for <i>BRCA1/2</i>Giulia Ongaro, Serena Petrocchi, Mariarosaria Calvello, et al.
American Journal of Men'S Health|August 7, 2025
Can Family Motivation Enhance Men's Uptake of Cascade Screening for Familial <i>BRCA1/2</i> Mutations?Giulia Ongaro, Serena Petrocchi, Mariarosaria Calvello, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 20, 2008
Psychological and clinical factors implicated in decision making about a trial of low-dose tamoxifen in hormone replacement therapy usersGabriella Rondanina, Matteo Puntoni, Gianluca Severi, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 12, 2015
Difficult choices for young patients with cancer: the supportive role of decisional counselingLeonora Chiavari, Sara Gandini, Irene Feroce, et al.
Cancer Prevention Research (Philadelphia, Pa.)|October 25, 2018
Quality of Life in a Randomized Breast Cancer Prevention Trial of Low-Dose Tamoxifen and Fenretinide in Premenopausal WomenDavide Serrano, Sara Gandini, Aliana Guerrieri-Gonzaga, et al.
Pageof 4